State of Texas Assessments of Academic Readiness

Dr. Gil Kliman and Tom Frinzi Appointed to STAAR Surgical Board of Directors

Retrieved on: 
Monday, June 1, 2020
Optical, Health, Surgery, Medical devices, Education in Texas, State of Texas Assessments of Academic Readiness, Ophthalmic, Ophthalmology

The appointment of Messrs. Kliman and Frinzi brings the total number of members on STAAR's Board to six.

Key Points: 
  • The appointment of Messrs. Kliman and Frinzi brings the total number of members on STAAR's Board to six.
  • "The addition of Dr. Gil Kliman and Tom Frinzi to the STAAR Surgical Board of Directors adds extensive ophthalmology, commercial and medical device expertise to STAAR," said Lou Silverman, Chairman of the Board of STAAR Surgical.
  • We believe Gil and Toms familiarity with the opportunities and challenges faced by growth-oriented ophthalmic companies will provide valuable insight.
  • On behalf of the entire Board, we look forward to Gil and Toms contributions to STAARs future successes.

STAAR Surgical to Report First Quarter Results on May 6, 2020

Retrieved on: 
Wednesday, April 15, 2020
Surgery, Manufacturing, Other Manufacturing, Health, Optical, Education in Texas, State of Texas Assessments of Academic Readiness, Conference call, NASDAQ, Finance, Economy of the United States

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended April 3, 2020 on Wednesday, May 6, 2020 after the market close.

Key Points: 
  • STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended April 3, 2020 on Wednesday, May 6, 2020 after the market close.
  • STAAR will host a conference call and webcast on Wednesday, May 6 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress.
  • To access the conference call (Conference ID 8879484), please dial 866-209-9722 for domestic participants and 825-312-2235 for international participants.
  • The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com .

STAAR Surgical Provides COVID-19 Business Update

Retrieved on: 
Monday, April 13, 2020
Optical, Health, Surgery, Clinical trials, Education in Texas, State of Texas Assessments of Academic Readiness, Intraocular lens, Forward-looking statement, Implant, Perception, Senses, Medicine

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided a business update relating to the evolving COVID-19 global health care concern.

Key Points: 
  • STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided a business update relating to the evolving COVID-19 global health care concern.
  • Our business in Japan remains strong and we have stocked our STAAR owned distribution center there to meet demand.
  • More than 1,000,000 Visian ICLs have been implanted to date and STAAR markets these lenses in over 75 countries.
  • We disclaim any intention or obligation to update or revise any financial projections or forward-looking statement due to new information or events.

Houston Area McDonald's Restaurants To Give Students And Teachers Free Breakfast To Kick Off STAAR Testing On April 7

Retrieved on: 
Friday, March 6, 2020
Restaurants, McDonald's, Oak Brook, Illinois, State of Texas Assessments of Academic Readiness, Companies, Food and drink

HOUSTON, March 6, 2020 /PRNewswire/ -- On Tuesday, April 7, from 6 a.m. to 9 a.m., Houston area McDonald's restaurants willprovide free breakfast to students taking the STAAR (State of Texas Assessments of Academic Readiness) test and their teachers.

Key Points: 
  • HOUSTON, March 6, 2020 /PRNewswire/ -- On Tuesday, April 7, from 6 a.m. to 9 a.m., Houston area McDonald's restaurants willprovide free breakfast to students taking the STAAR (State of Texas Assessments of Academic Readiness) test and their teachers.
  • "This offer is available at McDonald's restaurants throughout the Greater Houston area so every child has the opportunity to start their morning with a balanced breakfast as we begin the STAAR testing period."
  • Houston Area McDonald's restaurants are also offering the same free breakfast to teachers grades threethrough eight with a valid school I.D.
  • The McDonald's Greater Houston Owner/Operators Association (GHOA) is a co-operative of local business owners who own and operate more than 300 McDonald's restaurants in Greater Houston.

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 26, 2020

Retrieved on: 
Wednesday, February 5, 2020
Surgery, Medical devices, Health, Optical, Clinical trials, Education in Texas, State of Texas Assessments of Academic Readiness, Conference call, NASDAQ, Finance, Economy of the United States

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended January 3, 2020 on Wednesday, February 26, 2020 after the market close.

Key Points: 
  • STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended January 3, 2020 on Wednesday, February 26, 2020 after the market close.
  • STAAR will host a conference call and webcast on Wednesday, February 26 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress.
  • To access the conference call (Conference ID 5411518), please dial 866-209-9722 for domestic participants and 825-312-2235 for international participants.
  • The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com .

STAAR CFO to Retire in 2020

Retrieved on: 
Wednesday, December 18, 2019
General Health, Surgery, Other Health, Health, Optical, Education in Texas, State of Texas Assessments of Academic Readiness

"On behalf of everyone at STAAR, I thank Deborah for her dedication and contributions during her more than two-decade career at STAAR," said Caren Mason, President and CEO.

Key Points: 
  • "On behalf of everyone at STAAR, I thank Deborah for her dedication and contributions during her more than two-decade career at STAAR," said Caren Mason, President and CEO.
  • I am appreciative that Deborah will remain with STAAR to help facilitate a smooth leadership transition and wish her all the best in her retirement."
  • "It has been a privilege to work alongside the talented and dedicated STAAR team," said Andrews.
  • STAAR is conducting an external search for its next CFO.

STAAR Surgical Announces FDA IDE Clinical Study Approval

Retrieved on: 
Wednesday, December 11, 2019
Medical devices, FDA, Health, Surgery, Clinical trials, Optical, Corrective lenses, Ophthalmology, Perception, Senses, Optometry, Vision, Eye, Intraocular lens, Contact lens, Glasses, State of Texas Assessments of Academic Readiness

STAAR looks forward to the next step in moving our trial forward, gaining Institutional Review Board (IRB) approval, and initiating the EVO/EVO+ clinical trial as soon as possible, which we anticipate will be during the first quarter of calendar 2020, said Caren Mason, President and CEO of STAAR Surgical.

Key Points: 
  • STAAR looks forward to the next step in moving our trial forward, gaining Institutional Review Board (IRB) approval, and initiating the EVO/EVO+ clinical trial as soon as possible, which we anticipate will be during the first quarter of calendar 2020, said Caren Mason, President and CEO of STAAR Surgical.
  • STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems.
  • These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses.
  • More than 1,000,000 Visian ICLs have been implanted to date and STAAR markets these lenses in over 75 countries.

For the Fifth Consecutive Year, Fifth Graders in Texas Districts Using STEMscopes Achieve Higher Passing Rates on STAAR Science Test

Retrieved on: 
Wednesday, October 23, 2019
Primary, Secondary, Education, Technology, Software, Other Science, Science, Texas, Education in Texas, State of Texas Assessments of Academic Readiness, United States, Garner Independent School District, Chico Independent School District

For the fifth year in a row, Texas school districts using the STEMscopes science curriculum from Accelerate Learning had higher passing rates on the State of Texas Assessments of Academic Readiness (STAAR) grade 5 science test, compared to districts that did not use STEMscopes.

Key Points: 
  • For the fifth year in a row, Texas school districts using the STEMscopes science curriculum from Accelerate Learning had higher passing rates on the State of Texas Assessments of Academic Readiness (STAAR) grade 5 science test, compared to districts that did not use STEMscopes.
  • In a new study of the 2018-19 STAAR science test, which included 403,811 fifth grade students, the average passing was 70 percent for all 1,148 Texas districts that include fifth grade.
  • In addition, STEMscopes districts had higher passing rates for economically disadvantaged, African American, Latino, and limited English proficient (LEP) students.
  • Districts that used the STEMscopes science curriculum continued to have significantly higher overall science achievement compared to districts that did not use STEMscopes.

STAAR Surgical to Report Third Quarter Results on October 30, 2019

Retrieved on: 
Wednesday, October 9, 2019
Health, Medical devices, Hospitals, Surgery, Optical, Education in Texas, State of Texas Assessments of Academic Readiness, Conference call, NASDAQ, Finance, Economy of the United States

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 27, 2019 on Wednesday, October 30, 2019 after the market close.

Key Points: 
  • STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 27, 2019 on Wednesday, October 30, 2019 after the market close.
  • STAAR will host a conference call and webcast on Wednesday, October 30 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress.
  • To access the conference call (Conference ID 7170127), please dial 855-765-5684 for domestic participants and 262-912-6252 for international participants.
  • The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com .

STAAR Surgical Announces FDA IDE Clinical Study Approval

Retrieved on: 
Tuesday, August 27, 2019
Surgery, Medical Supplies, FDA, Clinical trials, General Health, Health, Optical, Corrective lenses, Health, Senses, Vision, Ophthalmology, Optometry, Eye, Contact lens, Intraocular lens, State of Texas Assessments of Academic Readiness, Food and Drug Administration

FDA also recommended study design modifications, which STAAR plans to incorporate into the investigational plan in a revised submission in the coming month.

Key Points: 
  • FDA also recommended study design modifications, which STAAR plans to incorporate into the investigational plan in a revised submission in the coming month.
  • STAAR looks forward to working with FDA to incorporate the recommended protocol modifications in order for the study design to support a marketing approval submission, said Caren Mason, President & CEO.
  • These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses.
  • More than 1,000,000 Visian ICLs have been implanted to date and STAAR markets these lenses in over 75 countries.